Rubella screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Rubella}} | {{Rubella}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{MJM}}, {{AKI}} | ||
{{MJM}} | |||
==Overview== | ==Overview== | ||
There | There are no standard screening test recommended for [[rubella]] [[infection]], however [[Pregnancy|pregnant]] women with suspected [[rubella]] [[infection]] must be investigated to confirm the diagnosis to prevent fetal anomalies.<ref name="pmid21267342">{{cite journal| author=Gerace TM| title=Rubella screening and immunization: its history and future-an ongoing challenge. | journal=Can Fam Physician | year= 1987 | volume= 33 | issue= | pages= 111-5 | pmid=21267342 | doi= | pmc=2218305 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21267342 }} </ref> | ||
==Screening== | ==Screening== | ||
There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.<ref name="USPSTF">U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.</ref><ref name="CDC"> Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.</ref> | There is no screening test for [[rubella]], however, if there is a high clinical suspicion of [[rubella]] infection during [[pregnancy]], [[serum]] [[IgG]] and [[IgM]] [[antibodies]] against [[rubella]] may be ordered. Also, if a [[pregnant]] woman proves to be not [[immune]] aganist [[rubella]], [[vaccination]] with [[MMR]] should be deferred till after delivery due to the theoretical [[teratogenic]] effects of the [[rubella]] [[vaccine]].<ref name="USPSTF">U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.</ref><ref name="CDC"> Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.</ref><ref name="pmid28370103">{{cite journal| author=Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P| title=Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis. | journal=J Med Virol | year= 2017 | volume= | issue= | pages= | pmid=28370103 | doi=10.1002/jmv.24818 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28370103 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Teratogens]] | [[Category:Teratogens]] | ||
| Line 17: | Line 19: | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Togaviruses]] | [[Category:Togaviruses]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Dermatology]] | |||
Latest revision as of 00:04, 30 July 2020
|
Rubella Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rubella screening On the Web |
|
American Roentgen Ray Society Images of Rubella screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Aravind Kuchkuntla, M.B.B.S[2]
Overview
There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.[1]
Screening
There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.[2][3][4]
References
- ↑ Gerace TM (1987). "Rubella screening and immunization: its history and future-an ongoing challenge". Can Fam Physician. 33: 111–5. PMC 2218305. PMID 21267342.
- ↑ U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.
- ↑ Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.
- ↑ Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P (2017). "Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis". J Med Virol. doi:10.1002/jmv.24818. PMID 28370103.